{
     "PMID": "28661258",
     "OWN": "NLM",
     "STAT": "In-Process",
     "LR": "20170918",
     "IS": "1461-7285 (Electronic) 0269-8811 (Linking)",
     "VI": "31",
     "IP": "9",
     "DP": "2017 Sep",
     "TI": "Antidepressant-like effect of a new selenium-containing compound is accompanied by a reduction of neuroinflammation and oxidative stress in lipopolysaccharide-challenged mice.",
     "PG": "1263-1273",
     "LID": "10.1177/0269881117711713 [doi]",
     "AB": "Organoselenium compounds and indoles have gained attention due to their wide range of pharmacological properties. Depression is a recurrent and disabling psychiatric illness and current evidences support that oxidative stress and neuroinflammation are mechanisms underlying the pathophysiology of this psychiatric condition. Here, we evaluated the effect of 3-((4-chlorophenyl)selanyl)-1-methyl-1H-indole (CMI) in lipopolysaccharide (LPS)-induced depressive-like behaviour, neuroinflammation and oxidative stress in male mice. CMI pre-treatment (20 and 50 mg/kg, intragastrically) significantly attenuated LPS (0.83 mg/kg, intraperitoneally)-induced depressive-like behaviour in mice by reducing the immobility time in the tail suspension test (TST) and forced swimming test (FST). CMI pre-treatment ameliorated LPS-induced neuroinflammation by reducing the levels of interleukin (IL)-1beta, IL-4 and IL-6 in the hippocampus and prefrontal cortex, as well as markers of oxidative damage. Additionally, we investigated the toxicological effects of CMI (200 mg/kg, i.g.) in the liver, kidney and brain through determination of the activity of aspartate aminotransferase (AST), alanine aminotransferase (ALT), delta-aminolevulinate dehydratase (delta-ALA-D) and creatinine levels. These biomarkers were not modified, indicating the possible absence of neuro-, hepato- and nephrotoxic effects. Our results suggest that CMI could be a therapeutic approach for the treatment of depression and other neuropsychiatric disorders associated with inflammation and oxidative stress.",
     "FAU": [
          "Casaril, Angela M",
          "Domingues, Micaela",
          "Fronza, Mariana",
          "Vieira, Beatriz",
          "Begnini, Karine",
          "Lenardao, Eder J",
          "Seixas, Fabiana K",
          "Collares, Tiago",
          "Nogueira, Cristina W",
          "Savegnago, Lucielli"
     ],
     "AU": [
          "Casaril AM",
          "Domingues M",
          "Fronza M",
          "Vieira B",
          "Begnini K",
          "Lenardao EJ",
          "Seixas FK",
          "Collares T",
          "Nogueira CW",
          "Savegnago L"
     ],
     "AD": "1 Programa de Pos-Graduacao em Biotecnologia (PPGB), Grupo de Pesquisa em Neurobiotecnologia, Biotecnologia/Centro de Desenvolvimento Tecnologico, Universidade Federal de Pelotas, Pelotas, RS, Brazil. 1 Programa de Pos-Graduacao em Biotecnologia (PPGB), Grupo de Pesquisa em Neurobiotecnologia, Biotecnologia/Centro de Desenvolvimento Tecnologico, Universidade Federal de Pelotas, Pelotas, RS, Brazil. 1 Programa de Pos-Graduacao em Biotecnologia (PPGB), Grupo de Pesquisa em Neurobiotecnologia, Biotecnologia/Centro de Desenvolvimento Tecnologico, Universidade Federal de Pelotas, Pelotas, RS, Brazil. 2 Programa de Pos-Graduacao em Quimica (PPGQ), Laboratorio de Sintese Organica Limpa, Quimica/Centro de Ciencias Quimicas, Farmaceuticas e de Alimentos, Universidade Federal de Pelotas, Pelotas, RS, Brazil. 3 Programa de Pos-Graduacao em Biotecnologia (PPGB), Grupo de Pesquisa em Oncologia Celular e Molecular, Laboratorio de Genomica Funcional, Biotecnologia/Centro de Desenvolvimento Tecnologico, Universidade Federal de Pelotas, Pelotas, RS, Brazil. 2 Programa de Pos-Graduacao em Quimica (PPGQ), Laboratorio de Sintese Organica Limpa, Quimica/Centro de Ciencias Quimicas, Farmaceuticas e de Alimentos, Universidade Federal de Pelotas, Pelotas, RS, Brazil. 3 Programa de Pos-Graduacao em Biotecnologia (PPGB), Grupo de Pesquisa em Oncologia Celular e Molecular, Laboratorio de Genomica Funcional, Biotecnologia/Centro de Desenvolvimento Tecnologico, Universidade Federal de Pelotas, Pelotas, RS, Brazil. 3 Programa de Pos-Graduacao em Biotecnologia (PPGB), Grupo de Pesquisa em Oncologia Celular e Molecular, Laboratorio de Genomica Funcional, Biotecnologia/Centro de Desenvolvimento Tecnologico, Universidade Federal de Pelotas, Pelotas, RS, Brazil. 4 Departamento de Bioquimica e Biologia Molecular, Centro de Ciencias Naturais e Exatas, Laboratorio de Sintese, Reatividade e Avaliacao Farmacologica e Toxicologica de Organocalcogenios, Universidade Federal de Santa Maria, Santa Maria, RS, Brazil. 1 Programa de Pos-Graduacao em Biotecnologia (PPGB), Grupo de Pesquisa em Neurobiotecnologia, Biotecnologia/Centro de Desenvolvimento Tecnologico, Universidade Federal de Pelotas, Pelotas, RS, Brazil.",
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article"
     ],
     "DEP": "20170629",
     "PL": "United States",
     "TA": "J Psychopharmacol",
     "JT": "Journal of psychopharmacology (Oxford, England)",
     "JID": "8907828",
     "OTO": [
          "NOTNLM"
     ],
     "OT": [
          "Organoselenium",
          "depression",
          "neuroinflammation",
          "oxidative stress",
          "toxicity"
     ],
     "EDAT": "2017/07/01 06:00",
     "MHDA": "2017/07/01 06:00",
     "CRDT": [
          "2017/06/30 06:00"
     ],
     "PHST": [
          "2017/07/01 06:00 [pubmed]",
          "2017/07/01 06:00 [medline]",
          "2017/06/30 06:00 [entrez]"
     ],
     "AID": [
          "10.1177/0269881117711713 [doi]"
     ],
     "PST": "ppublish",
     "SO": "J Psychopharmacol. 2017 Sep;31(9):1263-1273. doi: 10.1177/0269881117711713. Epub 2017 Jun 29.",
     "term": "hippocampus"
}